# Plan titration with your clinician

Published by Pawel Jozefiak. [About this project](https://adhd100.jock.pl/about/), [How we check sources](https://adhd100.jock.pl/methodology/)

- Canonical: https://adhd100.jock.pl/plan-clinician-led-titration/
- Language: en
- First published: 2026-09-29
- Evidence checked: 2026-09-29, using AI-assisted source verification
- Clinical review: Not clinically reviewed
- Number 5 of 100 in the list: https://adhd100.jock.pl/#plan-clinician-led-titration

Planned check-ins on what is helping and which side effects show up let your clinician find treatment that fits.

**The number:** Titrate medication to useful benefit with tolerable adverse effects ([American Academy of Pediatrics, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC7067282/))

## The evidence

- How sure: Certainty of evidence: Guideline advice, not formally graded. Measured in people with ADHD.
- Evidence grade: A. Grade A: moderate or high certainty evidence in people with ADHD, or an explicit ADHD guideline recommendation.
- Basis: AAP key action statement 6 (AAP evidence grade B, strong recommendation) and NICE NG87 1.7.26 to 1.7.27; no GRADE certainty for the process
- Benefit: 85/100. The benefit score is an editorial prioritization for the general list, weighted by certainty. It is not a prediction of what will happen for you.

## Why it matters

Titration means your clinician adjusts treatment step by step while checking whether it helps and what unwanted effects appear. The AAP recommends aiming for the most useful benefit with adverse effects you can tolerate. NICE recommends recording symptoms, impairment and adverse effects at each dose change and reviewing progress regularly with a specialist. There is no universal best dose or fixed timetable, and these recommendations put no number on the benefit of keeping a symptom record.

## How to do it

1. Before the titration review, agree the main problems treatment should help with.
2. Ask what the clinic wants to hear about symptoms and side effects, and use its form if it has one.
3. Include what has changed in sleep, appetite, mood and how your days go.
4. Confirm the next review date and how to reach the team if something goes wrong before then.

## Talk to a clinician first

The prescriber directs every medication change. Report worrying effects promptly instead of waiting for the next routine review.

## Putting it into practice

### Start now

- 1 minute: Add one change you've noticed, good or bad, to a note titled 'next review'.
- 5 minutes: Write a few lines on attention, how your days are going, sleep, appetite and mood.
- 15 minutes: Ask the clinic which feedback form they use, and write your questions for the next review.

### What it looks like

- Bring one change that helped and one unwanted effect to the next review.
- For a child, put their own experience next to a short teacher report when the clinic asks for one.

### Common mistakes

- If you only watch for better concentration, you can miss side effects. Report both.
- Forgot the form? The appointment still matters. Bring whatever information you have.

### A structured start

**Make reviews informative**

1. Agree treatment goals and a simple way to report changes.
2. Provide the requested feedback during clinician-led titration.
3. Review benefit, adverse effects and the next monitoring plan.

### Trusted how-to guides

- [Common questions about methylphenidate for adults](https://www.nhs.uk/medicines/methylphenidate-adults/common-questions-about-methylphenidate-for-adults/), NHS
- [Tips for Talking With a Health Care Provider About Your Mental Health](https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider), NIMH

## Sources

- [Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents](https://pmc.ncbi.nlm.nih.gov/articles/PMC7067282/), American Academy of Pediatrics, 2019 (Tier 1 guideline)
- [Attention deficit hyperactivity disorder: diagnosis and management (NG87), recommendations](https://www.nice.org.uk/guidance/ng87/chapter/Recommendations), NICE, 2019 (Tier 1 guideline)
- [Common questions about methylphenidate for adults](https://www.nhs.uk/medicines/methylphenidate-adults/common-questions-about-methylphenidate-for-adults/), NHS, 2025 (Tier 1 guideline)

---

General information about ADHD, not a diagnosis or an individual treatment plan. Tailoring changes the order of suggestions; it does not assess you. Medication decisions belong with you and a qualified clinician.

Report an error: meet@jock.pl

Reuse: CC BY 4.0, https://creativecommons.org/licenses/by/4.0/